One study suggested that AKAP1 can serve as a biomarker for hepatocellular carcinoma with qPCR and immunostaining evidence showing AKAP1 upregulation in tumors along with a correlation with poor prognosis [57]. The gene discussed is AKAP1; the disease is hepatocellular carcinoma.